Review: taking Xanax and Keppra together


Summary

Drug interactions are reported among people who take Xanax and Keppra together. This review analyzes the effectiveness and drug interactions between Xanax and Keppra. It is created by eHealthMe based on reports of 759 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Xanax and Keppra >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Xanax

Xanax has active ingredients of alprazolam. It is often used in stress and anxiety. (latest outcomes from Xanax 65,513 users)

Keppra

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. (latest outcomes from Keppra 24,568 users)

On Aug, 18, 2016

759 people who take Xanax, Keppra are studied.


Number of reports submitted per year:

Xanax and Keppra drug interactions.

Drug effectiveness over time:

Xanax:
  • < 1 month: 60.0% - (3 of 5 people)
  • 1 - 6 months: 50.0% - (1 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 3 people)
  • 1 - 2 years: 33.0% - (1 of 3 people)
  • 2 - 5 years: 50.0% - (4 of 8 people)
  • 5 - 10 years: 50.0% - (2 of 4 people)
  • 10+ years: 66.0% - (2 of 3 people)
  • not specified: 0.0% - (0 of 1 people)
Keppra:
  • < 1 month: 0.0% - (0 of 4 people)
  • 1 - 6 months: 33.0% - (1 of 3 people)
  • 6 - 12 months: 42.0% - (3 of 7 people)
  • 1 - 2 years: 75.0% - (3 of 4 people)
  • 2 - 5 years: 14.0% - (1 of 7 people)
  • 5 - 10 years: 100.0% - (2 of 2 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Xanax:
  • female: 64.0% - (11 of 17 people)
  • male: 16.0% - (2 of 12 people)
Keppra:
  • female: 43.0% - (7 of 16 people)
  • male: 25.0% - (3 of 12 people)

Drug effectiveness by age:

Xanax:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 33.0% - (1 of 3 people)
  • 20-29: 55.0% - (5 of 9 people)
  • 30-39: 37.0% - (3 of 8 people)
  • 40-49: 20.0% - (1 of 5 people)
  • 50-59: 50.0% - (1 of 2 people)
  • 60+: 100.0% - (2 of 2 people)
Keppra:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 50.0% - (1 of 2 people)
  • 20-29: 50.0% - (5 of 10 people)
  • 30-39: 25.0% - (2 of 8 people)
  • 40-49: 20.0% - (1 of 5 people)
  • 50-59: 0.0% - (0 of 2 people)
  • 60+: 100.0% - (1 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • insomnia
  • cough
  • cyanosis
  • ammonia increased
  • atrial septal defect
  • autonomic nervous system imbalance
  • constipation
  • crying
  • diarrhoea
  • ear congestion
1 - 6 months:
  • diverticulitis
  • large intestine perforation
  • cardiovascular disorder
  • convulsion
  • cytolytic hepatitis
  • hepatic failure
  • tumour haemorrhage
  • aggression
  • alanine aminotransferase increased
  • cholestasis
6 - 12 months:
  • anxiety, apprehension, feeling uptight, jitters, stress, stress and anxiety, tension
  • ocd
  • ammonia increased
  • atrial septal defect
  • autonomic nervous system imbalance
  • constipation
  • cough
  • crying
  • cyanosis
  • diarrhoea
1 - 2 years:
  • insomnia
  • ammonia increased
  • atrial septal defect
  • autonomic nervous system imbalance
  • constipation
  • cough
  • crying
  • cyanosis
  • diarrhoea
  • ear congestion
2 - 5 years:
  • convulsion
  • fall
  • jaw fracture
  • short-term memory loss
  • anger
  • aura
  • confusion
  • frustration
  • headaches
  • heartburn - chronic
5 - 10 years:
  • aura
  • b-cell lymphoma
  • blood cholesterol increased
  • bone neoplasm malignant
  • colon cancer
  • confusion
  • diabetes mellitus
  • drug ineffective
  • anal cancer stage 0
  • anger
10+ years:
  • agitation
  • anxiety
  • convulsion
  • depression
  • loss of consciousness
  • pain - abdomen
  • suicidal ideation
  • tagamet
not specified:
  • convulsion
  • fall
  • nausea
  • vomiting
  • pain
  • headache
  • dizziness
  • dyspnoea
  • drug ineffective
  • pneumonia

Most common drug interactions by gender *:

female:
  • convulsion
  • pain
  • nausea
  • fall
  • vomiting
  • dizziness
  • headache
  • asthenia
  • drug ineffective
  • pneumonia
male:
  • convulsion
  • insomnia
  • diarrhoea
  • pyrexia
  • cough
  • road traffic accident
  • constipation
  • rhinorrhoea
  • cyanosis
  • ammonia increased

Most common drug interactions by age *:

2-9:
  • drug dependence
  • hyperhidrosis
  • hypersensitivity
  • hypoglycaemia
  • pallor
  • blood chloride decreased
  • inappropriate antidiuretic hormone secretion
  • leukocytosis
  • neutrophilia
  • syncope
10-19:
  • electrocardiogram qt prolonged
  • tic
  • accidental overdose
  • anxiety
  • blood prolactin increased
  • depression
  • drug toxicity
  • lethargy
  • musculoskeletal stiffness
  • suicidal ideation
20-29:
  • anxiety, apprehension, feeling uptight, jitters, stress, stress and anxiety, tension
  • ocd
  • convulsion
  • nephrolithiasis
  • pain
  • drug ineffective
  • grand mal convulsion
  • renal failure acute
  • febrile neutropenia
  • nausea
30-39:
  • vomiting
  • convulsion
  • deep vein thrombosis
  • fall
  • insomnia
  • syncope
  • pneumonia
  • suicidal ideation
  • confusional state
  • drug ineffective
40-49:
  • convulsion
  • headache
  • dizziness
  • malaise
  • pain
  • fall
  • diarrhoea
  • insomnia
  • pain in extremity
  • visual impairment
50-59:
  • convulsion
  • asthenia
  • malaise
  • diarrhoea
  • dyspnoea
  • fall
  • vomiting
  • fatigue
  • inappropriate antidiuretic hormone secretion
  • nausea
60+:
  • convulsion
  • nausea
  • headache
  • pain
  • fall
  • pneumonia
  • dizziness
  • vomiting
  • dyspnoea
  • hypotension

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Xanax and Keppra?

Can you answer these questions?

More questions for: Xanax, Keppra

You may be interested in these reviews

More reviews for: Xanax, Keppra

On eHealthMe, Xanax (alprazolam) is often used to treat stress and anxiety. Keppra (levetiracetam) is often used to treat epilepsy. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.